Delayed cerebral ischemia after subarachnoid hemorrhage: A systematic review of clinical, laboratory, and radiological predictors

Stroke

Volumn 44, Issue 1, 2013, Pages 43-54

  De Rooij, Nicolien K ^a   Rinkel, Gabriel J E ^a   Dankbaar, Jan Willem ^a   Frijns, Catharina J M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

delayed cerebral ischemia; predictor; review; subarachnoid hemorrhage

Indexed keywords

ACETYLSALICYLIC ACID; HEMOGLOBIN; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; BLOOD FLOW; BRAIN ISCHEMIA; CONSCIOUSNESS; HEMATOLOGIC DISEASE; HUMAN; HYDROCEPHALUS; HYPERTENSION; HYPOMAGNESEMIA; MEDLINE; MIGRAINE; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; SUBARACHNOID HEMORRHAGE; SYSTEMATIC REVIEW; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TRANSCRANIAL DOPPLER;

BRAIN ISCHEMIA; HUMANS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SMOKING; SUBARACHNOID HEMORRHAGE; TIME FACTORS;

EID: 84872093513     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.112.674291     Document Type: Article

References (61)

1. Roos YB, de Haan RJ, Beenen LF, Groen RJ, Albrecht KW, Vermeulen M. Complications and outcome in patients with aneurysmal subarachnoid haemorrhage: a prospective hospital based cohort study in the Netherlands. J Neurol Neurosurg Psychiatr. 2000;68:337-341.
2. van Gijn J, Kerr RS, Rinkel GJ. Subarachnoid haemorrhage. Lancet. 2007;369:306-318.
3. Adams HP Jr, Kassell NF, Torner JC, Haley EC Jr. Predicting cerebral ischemia after aneurysmal subarachnoid hemorrhage: influences of clinical condition, CT results, and antifibrinolytic therapy. A report of the Cooperative Aneurysm Study. Neurology. 1987;37:1586-1591.
4. Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery. 1980;6:1-9.
5. Post B, Merkus MP, de Haan RJ, Speelman JD; CARPA Study Group. Prognostic factors for the progression of Parkinson's disease: a systematic review. Mov Disord. 2007;22:1839-1851; quiz 1988.
6. Altman DG. Systematic reviews of evaluations of prognostic variables. BMJ. 2001;323:224-228.
7. Borghouts JA, Koes BW, Bouter LM. The clinical course and prognostic factors of non-specific neck pain: a systematic review. Pain. 1998;77:1-13.
8. Alaraj A, Wallace A, Mander N, Aletich V, Charbel FT, Amin-Hanjani S. Outcome following symptomatic cerebral vasospasm on presentation in aneurysmal subarachnoid hemorrhage: coiling vs. clipping. World Neurosurg. 2010;74:138-142.
9. Ameriso SF, Wong VL, Ishii H, Quismorio FP Jr, Giannotta SL, Meiselman HJ, et al. Hematogenous factors and prediction of delayed ischemic deficit after subarachnoid hemorrhage. Stroke. 1992;23:1404-1409.
10. Badjatia N, Topcuoglu MA, Buonanno FS, Smith EE, Nogueira RG, Rordorf GA, et al. Relationship between hyperglycemia and symptomatic vasospasm after subarachnoid hemorrhage. Crit Care Med. 2005;33:1603-1609; quiz 1623.
11. Bakker AM, Dorhout Mees SM, Algra A, Rinkel GJ. Extent of acute hydrocephalus after aneurysmal subarachnoid hemorrhage as a risk factor for delayed cerebral infarction. Stroke. 2007;38:2496-2499.
12. Carrera E, Schmidt JM, Oddo M, Ostapkovich N, Claassen J, Rincon F, et al. Transcranial Doppler ultrasound in the acute phase of aneurysmal subarachnoid hemorrhage. Cerebrovasc Dis. 2009;27:579-584.
13. Charpentier C, Audibert G, Guillemin F, Civit T, Ducrocq X, Bracard S, et al. Multivariate analysis of predictors of cerebral vasospasm occurrence after aneurysmal subarachnoid hemorrhage. Stroke. 1999;30:1402-1408.
14. Collignon FP, Friedman JA, Piepgras DG, Pichelmann MA, McIver JI, Toussaint LG 3rd, et al. Serum magnesium levels as related to symptomatic vasospasm and outcome following aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2004;1:441-448.
15. Conway JE, Tamargo RJ. Cocaine use is an independent risk factor for cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke. 2001;32:2338-2343.
16. Dhar R, Diringer MN. The burden of the systemic inflammatory response predicts vasospasm and outcome after subarachnoid hemorrhage. Neurocrit Care. 2008;8:404-412.
17. Dreier JP, Kremer C, Lammers G, Lohmann F, Hansen HC, Valdueza JM. Migraine and delayed ischaemic neurological deficit after subarachnoid haemorrhage in women: a case-control study. Eur J Neurol. 2007;14:1363-1368.
18. Dumont T, Rughani A, Silver J, Tranmer BI. Diabetes mellitus increases risk of vasospasm following aneurysmal subarachnoid hemorrhage independent of glycemic control. Neurocrit Care. 2009;11:183-189.
19. Fujii Y, Takeuchi S, Sasaki O, Minakawa T, Koike T, Tanaka R. Serial changes of hemostasis in aneurysmal subarachnoid hemorrhage with special reference to delayed ischemic neurological deficits. J Neurosurg. 1997;86:594-602.
20. Hijdra A, van Gijn J, Nagelkerke NJ, Vermeulen M, van Crevel H. Prediction of delayed cerebral ischemia, rebleeding, and outcome after aneurysmal subarachnoid hemorrhage. Stroke. 1988;19:1250-1256.
21. Hirashima Y, Kurimoto M, Hori E, Origasa H, Endo S. Lower incidence of symptomatic vasospasm after subarachnoid hemorrhage owing to ruptured vertebrobasilar aneurysms. Neurosurgery. 2005;57:1110-1116; discussion 1110.
22. Hop JW, Rinkel GJ, Algra A, van Gijn J. Initial loss of consciousness and risk of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Stroke. 1999;30:2268-2271.
23. Howington JU, Kutz SC, Wilding GE, Awasthi D. Cocaine use as a predictor of outcome in aneurysmal subarachnoid hemorrhage. J Neurosurg. 2003;99:271-275.
24. Inagawa T. Cerebral vasospasm in elderly patients with ruptured intracranial aneurysms. Surg Neurol. 1991;36:91-98.
25. Inagawa T. Site of ruptured intracranial saccular aneurysms in patients in Izumo City, Japan. Cerebrovasc Dis. 2010;30:72-84.
26. Inagawa T. Size of ruptured intracranial saccular aneurysms in patients in Izumo City, Japan. World Neurosurg. 2010;73:84-92; discussion e11.
27. Jeon IC, Chang CH, Choi BY, Kim MS, Kim SW, Kim SH. Cardiac troponin I elevation in patients with aneurysmal subarachnoid hemorrhage. J Korean Neurosurg Soc. 2009;46:99-102.
28. Juvela S. Alcohol consumption as a risk factor for poor outcome after aneurysmal subarachnoid haemorrhage. BMJ. 1992;304:1663-1667.
29. Juvela S. Aspirin and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. J Neurosurg. 1995;82:945-952.
30. Juvela S, Kuhmonen J, Siironen J. C-reactive protein as predictor for poor outcome after aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien). 2012;154:397-404.
31. Kale SP, Edgell RC, Alshekhlee A, Haghighi AB, Sweeny J, Felton J, et al. Age-Associated Vasospasm in Aneurysmal Subarachnoid Hemorrhage. J Stroke Cerebrovasc Dis. June 28, 2011. doi:10. 1016/j. jstrokecerebrovasdis. 2011. 05. 024. Accessed June 28, 2011.
32. Kerner A, Schlenk F, Sakowitz O, Haux D, Sarrafzadeh A. Impact of hyperglycemia on neurological deficits and extracellular glucose levels in aneurysmal subarachnoid hemorrhage patients. Neurol Res. 2007;29:647-653.
33. Kongable GL, Lanzino G, Germanson TP, Truskowski LL, Alves WM, Torner JC, et al. Gender-related differences in aneurysmal subarachnoid hemorrhage. J Neurosurg. 1996;84:43-48.
34. Kremer C, Groden C, Hansen HC, Grzyska U, Zeumer H. Outcome after endovascular treatment of Hunt and Hess grade IV or V aneurysms: comparison of anterior versus posterior circulation. Stroke. 1999;30:2617-2622.
35. Krishnamurthy S, Kelleher JP, Lehman EB, Cockroft KM. Effects of tobacco dose and length of exposure on delayed neurological deterioration and overall clinical outcome after aneurysmal subarachnoid hemorrhage. Neurosurgery. 2007;61:475-480; discussion 480.
36. Kruyt ND, Roos YW, Dorhout Mees SM, van den Bergh WM, Algra A, Rinkel GJ, et al. High mean fasting glucose levels independently predict poor outcome and delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatr. 2008;79:1382-1385.
37. Lanzino G, Kassell NF, Germanson TP, Kongable GL, Truskowski LL, Torner JC, et al. Age and outcome after aneurysmal subarachnoid hemorrhage: why do older patients fare worse? J Neurosurg. 1996;85:410-418.
38. Lasner TM, Weil RJ, Riina HA, King JT Jr, Zager EL, Raps EC, et al. Cigarette smoking-induced increase in the risk of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg. 1997;87:381-384.
39. Macdonald RL, Rosengart A, Huo D, Karrison T. Factors associated with the development of vasospasm after planned surgical treatment of aneurysmal subarachnoid hemorrhage. J Neurosurg. 2003;99:644-652.
40. Magge SN, Chen HI, Ramakrishna R, Cen L, Chen Z, Elliott JP, et al. Association of a younger age with an increased risk of angiographic and symptomatic vasospasms following subarachnoid hemorrhage. J Neurosurg. 2010;112:1208-1215.
41. McGirt MJ, Blessing R, Alexander MJ, Nimjee SM, Woodworth GF, Friedman AH, et al. Risk of cerebral vasopasm after subarachnoid hemorrhage reduced by statin therapy: A multivariate analysis of an institutional experience. J Neurosurg. 2006;105:671-674.
42. Moskowitz SI, Ahrens C, Provencio JJ, Chow M, Rasmussen PA. Prehemorrhage statin use and the risk of vasospasm after aneurysmal subarachnoid hemorrhage. Surg Neurol. 2009;71:311-317, discussion 317.
43. Naidech AM, Drescher J, Ault ML, Shaibani A, Batjer HH, Alberts MJ. Higher hemoglobin is associated with less cerebral infarction, poor outcome, and death after subarachnoid hemorrhage. Neurosurgery. 2006;59:775-779; discussion 779.
44. Niikawa S, Hara S, Ohe N, Miwa Y, Ohkuma A. Correlation between blood parameters and symptomatic vasospasm in subarachnoid hemorrhage patients. Neurol Med Chir (Tokyo). 1997;37:881-884; discussion 884.
45. Parra A, Kreiter KT, Williams S, Sciacca R, Mack WJ, Naidech AM, et al. Effect of prior statin use on functional outcome and delayed vasospasm after acute aneurysmal subarachnoid hemorrhage: a matched controlled cohort study. Neurosurgery. 2005;56:476-484; discussion 476.
46. Rabinstein AA, Friedman JA, Weigand SD, McClelland RL, Fulgham JR, Manno EM, et al. Predictors of cerebral infarction in aneurysmal subarachnoid hemorrhage. Stroke. 2004;35:1862-1866.
47. Rothoerl RD, Axmann C, Pina AL, Woertgen C, Brawanski A. Possible role of the C-reactive protein and white blood cell count in the pathogenesis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg Anesthesiol. 2006;18:68-72.
48. Ryttlefors M, Enblad P, Ronne-Engström E, Persson L, Ilodigwe D, Macdonald RL. Patient age and vasospasm after subarachnoid hemorrhage. Neurosurgery. 2010;67:911-917.
49. Schuiling WJ, de Weerd AW, Dennesen PJ, Algra A, Rinkel GJ. The simplified acute physiology score to predict outcome in patients with subarachnoid hemorrhage. Neurosurgery. 2005;57:230-236; discussion 230.
50. Schuiling WJ, Algra A, de Weerd AW, Leemans P, Rinkel GJ. ECG abnormalities in predicting secondary cerebral ischemia after subarachnoid haemorrhage. Acta Neurochir (Wien). 2006;148:853-858; discussion 858.
51. Shiue I, Arima H, Hankey GJ, Anderson CS. Location and size of ruptured intracranial aneurysm and serious clinical outcomes early after subarachnoid hemorrhage: a population-based study in Australasia. Cerebrovasc Dis. 2011;31:573-579.
52. Singhal AB, Topcuoglu MA, Dorer DJ, Ogilvy CS, Carter BS, Koroshetz WJ. SSRI and statin use increases the risk for vasospasm after subarachnoid hemorrhage. Neurology. 2005;64:1008-1013.
53. Toussaint LG 3rd, Friedman JA, Wijdicks EF, Piepgras DG, Pichelmann MA, McIver JI, et al. Influence of aspirin on outcome following aneurysmal subarachnoid hemorrhage. J Neurosurg. 2004;101:921-925.
54. van den Bergh WM, Algra A, van der Sprenkel JW, Tulleken CA, Rinkel GJ. Hypomagnesemia after aneurysmal subarachnoid hemorrhage. Neurosurgery. 2003;52:276-281; discussion 281.
55. van den Bergh WM, Algra A, Elias R, Rinkel GJ. Extent of atherosclerosis and prognosis of patients with aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien). 2006;148:1065-1069; discussion 1069.
56. Weir BK, Kongable GL, Kassell NF, Schultz JR, Truskowski LL, Sigrest A. Cigarette smoking as a cause of aneurysmal subarachnoid hemorrhage and risk for vasospasm: a report of the Cooperative Aneurysm Study. J Neurosurg. 1998;89:405-411.
57. Yoshimoto Y, Tanaka Y, Hoya K. Acute systemic inflammatory response syndrome in subarachnoid hemorrhage. Stroke. 2001;32:1989-1993.
58. Yousef K, Crago E, Kuo CW, Horowitz M, Hravnak M. Predictors of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: a cardiac focus. Neurocrit Care. 2010;13:366-372.
59. Zheng B, Qiu Y, Jin H, Wang L, Chen X, Shi C, et al. A predictive value of hyponatremia for poor outcome and cerebral infarction in high-grade aneurysmal subarachnoid haemorrhage patients. J Neurol Neurosurg Psychiatr. 2011;82:213-217.
60. Harrod CG, Bendok BR, Batjer HH. Prediction of cerebral vasospasm in patients presenting with aneurysmal subarachnoid hemorrhage: a review. Neurosurgery. 2005;56:633-654; discussion 633.
61. Adams HP Jr, Putman SF, Kassell NF, Torner JC. Prevalence of diabetes mellitus among patients with subarachnoid hemorrhage. Arch Neurol. 1984;41:1033-1035.